BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34957712)

  • 1. [NEPHROTIC SYNDROME RECURRENCE POST-RENAL TRANSPLANTATION: 10 YEARS' EXPERIENCE AT SCHNEIDER CHILDREN'S MEDICAL CENTER IN ISRAEL].
    Fisher D; Borovitz Y; Alfandari H; LEvi S; Hamdani G; Dagan A; Davidovits M; Landau D; Haskin O
    Harefuah; 2021 Dec; 160(12):786-792. PubMed ID: 34957712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
    Al-Mousily MF; Nicoara O; Selewski DT; Nadig S; Twombley K
    J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience.
    Morello W; Puvinathan S; Puccio G; Ghiggeri GM; Dello Strologo L; Peruzzi L; Murer L; Cioni M; Guzzo I; Cocchi E; Benetti E; Testa S; Ghio L; Caridi G; Cardillo M; Torelli R; Montini G
    J Nephrol; 2020 Aug; 33(4):849-857. PubMed ID: 31617157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initial steroid response on transplant outcomes in children with steroid-resistant nephrotic syndrome.
    Francis A; Prestidge C; Kausman J; Le Page A; Larkins N; McCarthy H;
    Pediatr Nephrol; 2022 May; 37(5):1149-1156. PubMed ID: 34709476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
    Bernard J; Bruel A; Allain-Launay E; Dantal J; Roussey G
    Pediatr Transplant; 2018 Jun; 22(4):e13175. PubMed ID: 29569812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to steroid and immunosuppressive therapies may predict post-transplant recurrence of steroid-resistant nephrotic syndrome.
    Miura K; Ando T; Kanda S; Hashimoto T; Kaneko N; Ishizuka K; Hamada R; Hataya H; Hotta K; Gotoh Y; Nishiyama K; Hamasaki Y; Shishido S; Fujita N; Hattori M
    Pediatr Transplant; 2022 Dec; 26(8):e14103. PubMed ID: 34309142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.
    Ding WY; Koziell A; McCarthy HJ; Bierzynska A; Bhagavatula MK; Dudley JA; Inward CD; Coward RJ; Tizard J; Reid C; Antignac C; Boyer O; Saleem MA
    J Am Soc Nephrol; 2014 Jun; 25(6):1342-8. PubMed ID: 24511128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S; Zolotnitskaya A; Del Rio M
    Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
    Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
    Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry.
    Trautmann A; Lipska-Ziętkiewicz BS; Schaefer F
    Front Pediatr; 2018; 6():200. PubMed ID: 30065916
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
    Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
    Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation.
    Bernard J; Lalieve F; Sarlat J; Perrin J; Dehoux L; Boyer O; Godron-Dubrasquet A; Harambat J; Decramer S; Caillez M; Bruel A; Allain-Launay E; Dantal J; Roussey G
    Pediatr Nephrol; 2020 Aug; 35(8):1499-1506. PubMed ID: 32306087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-emptive rituximab and plasma exchange does not prevent disease recurrence following living donor renal transplantation in high-risk idiopathic SRNS.
    Shenoy M; Lennon R; Plant N; Wallace D; Kaur A
    Pediatr Nephrol; 2020 Jun; 35(6):1081-1084. PubMed ID: 32124030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism in children with steroid-resistant nephrotic syndrome.
    Dagan A; Cleper R; Krause I; Blumenthal D; Davidovits M
    Nephrol Dial Transplant; 2012 Jun; 27(6):2171-5. PubMed ID: 22167590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.
    Al-Mousily M; Nicoara O; Selewski DT; Twombley K
    Pediatr Nephrol; 2022 Mar; 37(3):585-592. PubMed ID: 34453196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children.
    Schachter AD; Harmon WE
    Pediatr Transplant; 2001 Dec; 5(6):406-9. PubMed ID: 11737765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
    Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.